• SENSEX 81,028.02
    1,718.01 (+2.17%)
  • BANKNIFTY 59,086.00
    1,312.35 (+2.27%)
  • Billionbrains
    208.75 112.02(%)
  • Lenskart Solut.
    733.10 767.40(%)
  • NSE
    1,953.95 1,953.95(%)
  • Cartrade Tech
    2,712.90 3,291.35(%)
  • Apar Inds.
    13,783.50 6,800.00(%)
  • Tonbo Imaging
    1,427.75 1,013.95(%)
  • M & M
    3,295.00 3,840.00(%)
  • Cummins India
    3,903.00 3,883.30(%)
  • HDFC Bank
    787.00 1,017.90(%)
  • ICICI Bank
    1,569.30 1,569.30(%)
  • Sai Life
    1,815.55 1,815.55(%)
  • Hitachi Energy
    26,720.00 16,104.00(%)
  • Avenue Super.
    3,408.40 3,104.00(%)
  • Axis Bank
    1,323.90 1,418.30(%)
  • Bharti Airtel
    2,120.00 2,174.70(%)
  • Larsen & Toubro
    4,118.90 4,440.00(%)
  • Jio Platforms
    1,390.00 1,356.40(%)
  • CG Power & Ind
    734.00 525.50(%)
  • Reliance Industries
    1,318.10 1,611.20(%)
  • SBI
    1,020.00 1,234.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Panacea Biotec Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 12420.0
  • ISIN : INE922B01023
344.00 -11 (-3.03%)
  • As on 06 Nov 2026 (EOD)

  • Today’s Low

    342.80

  • Today’s High

    355.05

  • Open

    355.00

  • Perv Close

    354.75

  • 52W Low

    292.40

  • 52W High

    647.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    2,107.03

  • Div & Yield %

    0.00

  • Book Value(₹)

    43.03

  • Debt-Equity Ratio

    -3.03

  • AGM Date

    06-Nov-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.02

  • Mar.Cap (₹Cr.)

    2,107.03

  • RONW (%)

    -4.07

  • ROCE (%)

    -3.34

Score Board

  • Equity (₹ in Cr.)

    6.13

  • BV (₹)

    43.00

  • Sales( ₹ in Cr.)

    413.49

  • NP (in Cr.)

    -29.91

  • NP Var(%)

    -96.0

  • Div%

    0.0

  • CPS (₹)

    -1.80

  • EPS (₹)

    -4.90

  • Traded Value (₹ in Lakhs)

    2,158.48

  • 52 Week High

    647.00

  • 52 Week Low

    292.40

  • Price BSE

    352.0

  • Price NSE

    355.00

  • Market Capital( in Cr.)

    2,158.48

  • P/C Ratio

    -193.10

  • P/E Ratio

    -72.10

  • Price Vs.BV

    -4.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 413.49 309.86 359.60 257.07 235.50 343.56
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 413.49 309.86 359.60 257.07 235.50 343.56
Other Income 18.00 16.62 24.91 34.44 12.57 20.75
Stock Adjustments 12.42 23.06 -17.79 -31.15 60.95 -14.24
Total Income 443.91 349.54 366.72 260.36 309.02 350.07
EXPENDITURE :            
Raw Materials 223.51 125.76 123.90 131.91 173.04 162.02
Power and Fuel Cost 26.43 28.46 25.33 22.43 26.51 20.78
Employee Cost 100.33 97.02 86.53 71.03 72.50 59.47
Other Manufacturing Expenses 37.90 41.12 48.20 36.31 40.76 45.75
Selling and Administration Expenses 39.67 36.34 29.99 23.41 45.82 30.87
Miscellaneous Expenses 15.91 11.14 13.71 3.45 10.51 9.97
Employee Benefit Expenses 100.33 97.02 86.53 71.03 72.50 59.47
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 443.75 339.84 327.65 288.54 369.13 328.85
Operating Profit 0.18 9.69 39.07 -28.20 -60.11 21.21
Interest 25.31 15.46 13.78 10.06 7.04 7.52
Gross Profit -25.13 -5.77 25.29 -38.26 -67.15 13.69
Depreciation 18.75 20.29 21.09 24.50 26.43 26.57
Profit Before Tax -43.88 -26.06 4.20 -62.76 -93.58 -12.88
Current Tax -1.59 0.00 0.64 0.00 0.00 2.27
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -12.38 -10.83 0.02 24.79 0.00 -0.71
Reported Net Profit -29.91 -15.23 3.55 -87.54 -93.58 -14.44
Extraordinary Items 0.00 0.06 0.05 5.30 0.01 3.26
Adjusted Net Profit -29.91 -15.29 3.50 -92.84 -93.59 -17.70
Adjustment below Net Profit 1.15 0.05 -0.06 -1.90 0.50 1.38
P & L Balance brought forward -189.08 -173.91 -177.40 -87.96 5.12 18.18
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -217.84 -189.08 -173.91 -177.40 -87.96 5.12
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -4.88 -2.49 0.58 -14.29 -15.28 -2.36
Earnings Per Share(Adj)-Unit Curr -4.88 -2.49 0.58 -14.29 -15.28 -2.36
Book Value 43.03 47.72 50.20 49.63 64.24 79.43
Book Value(Adj)-Unit Curr 43.03 47.72 50.20 49.63 64.24 79.43

Shareholding Pattern

  • Promoter Group

    72.48%

  • Public Share Holding

    27.52%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 42,080,736 68.70 42,080,736 5
Partnership Firms-Indian (Promoter & Group) 2,313,454 3.78 2,313,454 2
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 44,394,190 72.48 44,394,190 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,683,735 2.75 1,683,735 21
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 678 0.00 678 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,511,673 2.47 1,511,673 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,196,086 5.22 3,196,086 31
2] Non Institution
Bodies Corporate 889,430 1.45 889,430 234
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 733,156 1.20 733,156 531
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 877,246 1.43 877,246 637
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 560,484 0.92 560,484 1
Individuals holding nominal share capital up to Rs. 1 lakh 9,048,457 14.77 8,907,237 31,444
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 104,251 0.17 104,251 15
Others 96,173 0.16 96,173 2
Sub Total 13,660,470 22.30 13,519,250 32,923
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 61,250,746 100.00 61,109,526 32,961

Company Background

Panacea Biotec LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Panacea Biotec Ltd
  • BSE Code : 12420.0
  • ISIN : INE922B01023

  • Incorporation Year

    1984

  • Registered Office

    Ambala-Chandigarh Highway
    , Lalru,
    Punjab-140501

  • Telephone

    91-1762-505900

  • FAX

  • Chairman

    Rajesh Jain

  • Managing Director

    Rajesh Jain

  • Company Secretary

  • Auditor

    Suresh Surana & Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Skyline Financial Services Pvt
    D-153/A 1st Flr,
    Okhla Industrial Are,Phase-I
    Mumbai - New Delhi-110020

Panacea Biotec Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Panacea Biotec 345.95 431.50 413.49 -97.18 0.00
Abbott India 26,340.05 7,217.19 6,929.05 34.66 43.78
Astrazeneca Phar 6,387.90 2,304.07 2,275.58 94.15 27.86
Glaxosmi. Pharma 2,524.85 3,932.76 3,790.20 37.52 58.17
Evonile Pharma 1,762.40 393.10 354.33 -1,087.90 15.94
Cipla 1,409.00 20,102.60 18,979.95 42.94 13.88
Bliss GVS Pharma 603.40 773.53 729.81 39.34 12.51
Amrutanjan Healt 513.30 520.13 502.55 25.90 24.16
Fermenta Biotec. 447.05 474.15 450.25 20.87 18.77
Guj. Themis Bio. 379.05 168.25 165.82 101.35 18.05
Ambalal Sarabhai 35.25 19.52 3.94 65.28 6.77